Company profile: DeVoro Medical
1.1 - Company Overview
Company description
- Provider of thrombectomy medical devices to restore blood flow, including the WOLF Thrombectomy Platform that captures and removes blood clots from the arterial and venous systems using finger-like prongs, without the need for a console or lytic agents.
Products and services
- WOLF Thrombectomy Platform: Medical-grade device that captures and removes blood clots from arterial and venous systems using finger-like prongs, operating without a console or lytic agents
- Arterial Thrombectomy Capability: Custom-engineered modality that mechanically captures and extracts arterial clots with finger-like prongs, streamlining procedures by eliminating console dependence and lytic agent requirements
- Venous Thrombectomy Capability: Industrial-grade component that grasps and removes venous blood clots via finger-like prongs, enabling console-free operation and avoidance of lytic agents within the venous system
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to DeVoro Medical
Quantum Genomics
HQ: France
Website
- Description: Provider of effective, well-tolerated therapeutic treatments for cardiovascular diseases, focused on controlling high blood pressure and preventing related risks such as heart failure, addressing unmet medical needs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Quantum Genomics company profile →
Applied Therapeutics
HQ: United States
Website
- Description: Provider of drug development targeting molecules/pathways in fatal or debilitating diseases, with programs: govorestat for Galactosemia (pediatric Phase 3 completed; MAA validated; NDA accepted; PDUFA date set), SORD Deficiency (positive pilot; ongoing Phase 3), PMM2-CDG (Phase 2-ready; Expanded Access), AT-001 for Diabetic Cardiomyopathy/Peripheral Neuropathy (Phase 3), and AT-003 for Diabetic Retinopathy (Phase 1-ready).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Applied Therapeutics company profile →
Reflectance Medical
HQ: United States
Website
- Description: Provider of the Mobile CareGuide sensor platform for noninvasive, continuous assessment of patient metabolic status; developing new technology to improve care of critically ill patients and reduce medical costs and deaths associated with conditions resulting in poor tissue perfusion and acidosis; its noninvasive CareGuide patient monitor continuously and quantitatively displays levels.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Reflectance Medical company profile →
CardioGenics
HQ: Turkey
Website
- Description: Provider of sensitive diagnostic test products to the IVD market.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CardioGenics company profile →
Voyage Medical
HQ: United States
Website
- Description: Provider of cardiac medical devices for the treatment of atrial fibrillation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Voyage Medical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for DeVoro Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to DeVoro Medical
2.2 - Growth funds investing in similar companies to DeVoro Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for DeVoro Medical
4.2 - Public trading comparable groups for DeVoro Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →